Diflorasone Diacetate

CHEMBL1200545 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
494.5 g/mol
LogP
3.0
Phase
4

The diacetate ester of diflorasone, the pharmaceutical form used in topical creams and ointments to treat severe inflammatory skin conditions. The ester form enhances skin penetration and activation within the skin layers. It is one of the more potent topical corticosteroids and should be used sparingly and for limited periods.

Moleküler Ağırlık

494,5000 g/mol

LogP

3,00

TPSA

107,00 Ų

Lipinski RO5

Geçer

Etki Mekanizması

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanizma

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C

InChI

InChI=1S/C26H32F2O7/c1-13-8-17-18-10-20(27)19-9-16(31)6-7-23(19,4)25(18,28)21(32)11-24(17,5)26(13,35-15(3)30)22(33)12-34-14(2)29/h6-7,9,13,17-18,20-21,32H,8,10-12H2,1-5H3/t13-,17-,18-,20-,21-,23-,24-,25-,26-/m0/s1

Molecular Formula

C26H32F2O7

HBD / HBA

1 / 9

Döndürülebilir Bağlar

6

Ağır Atomlar

35

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

The diacetate ester of diflorasone, the pharmaceutical form used in topical creams and ointments to treat severe inflammatory skin conditions. The ester form enhances skin penetration and activation within the skin layers. It is one of the more potent topical corticosteroids and should be used sparingly and for limited periods.

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Yes, Diflorasone Diacetate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200545. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 71414. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.